Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection

Identifieur interne : 00A598 ( Main/Merge ); précédent : 00A597; suivant : 00A599

Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection

Auteurs : S. Mansour [Royaume-Uni] ; H. Woffendin [Royaume-Uni] ; S. Mitton [Royaume-Uni] ; I. Jeffery [Royaume-Uni] ; T. Jakins [Royaume-Uni] ; S. Kenwrick [Royaume-Uni] ; V. A. Murday [Royaume-Uni]

Source :

RBID : Pascal:01-0190025

Descripteurs français

English descriptors

Abstract

Familial Incontinentia pigmenti (IP) is a rare X-linked dominant condition. The affected cases have characteristic skin lesions, hair, eye, teeth and nail abnormalities and may also have neurological problems. The diagnosis has traditionally been made on clinical grounds. Segregation analysis has suggested that it is lethal in males. Only one liveborn male has been reported who died at one day of age. Female cases of IP survive because of the moderating effects of Lyonization. This child was the affected son of a female with IP. He had a novel phenotype consistent with hypohidrotic ectodermal dysplasia with immune deficiency (HED-ID) but with additional features: he had major problems with hematological disturbances, failure to thrive due to malabsorption, recurrent infections, generalized osteosclerosis and lymphedema of his lower limbs. He also demonstrated some typical features of IP with a generalized reticular skin hyperpigmentation, sparse hair and delayed eruption of teeth. The gene for NEMO (NF-κB Essential Modulator) has recently been shown to be mutated in cases of IP. Furthermore, most (80%) of patients possess a recurrent genomic rearrangement that deletes part of the gene resulting in an inactive NEMO protein. In the male case described here, a NEMO stop codon mutation has been identified that has arisen de novo in his affected mother. This mutation is likely to have a less severe effect on NEMO activity and may explain why this child survived for two years and 7 months.

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:01-0190025

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection</title>
<author>
<name sortKey="Mansour, S" sort="Mansour, S" uniqKey="Mansour S" first="S." last="Mansour">S. Mansour</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Department of Medical Genetics, St George's Hospital Medical School</s1>
<s2>Tooting, London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Woffendin, H" sort="Woffendin, H" uniqKey="Woffendin H" first="H." last="Woffendin">H. Woffendin</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Wellcome Trust Centre for Molecular Mechanisms of Disease, Cambridge University Department of Medicine, Cambridge, Addenbrooke's Hospital, Hills Road</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Cambridge</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mitton, S" sort="Mitton, S" uniqKey="Mitton S" first="S." last="Mitton">S. Mitton</name>
<affiliation wicri:level="3">
<inist:fA14 i1="03">
<s1>Department of Child Health, St George's Hospital Medical School</s1>
<s2>Tooting, London</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jeffery, I" sort="Jeffery, I" uniqKey="Jeffery I" first="I." last="Jeffery">I. Jeffery</name>
<affiliation wicri:level="3">
<inist:fA14 i1="04">
<s1>Department of Pathology, St George's Hospital Medical School</s1>
<s2>Tooting, London</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jakins, T" sort="Jakins, T" uniqKey="Jakins T" first="T." last="Jakins">T. Jakins</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Wellcome Trust Centre for Molecular Mechanisms of Disease, Cambridge University Department of Medicine, Cambridge, Addenbrooke's Hospital, Hills Road</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Cambridge</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kenwrick, S" sort="Kenwrick, S" uniqKey="Kenwrick S" first="S." last="Kenwrick">S. Kenwrick</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Wellcome Trust Centre for Molecular Mechanisms of Disease, Cambridge University Department of Medicine, Cambridge, Addenbrooke's Hospital, Hills Road</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Cambridge</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Murday, V A" sort="Murday, V A" uniqKey="Murday V" first="V. A." last="Murday">V. A. Murday</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Department of Medical Genetics, St George's Hospital Medical School</s1>
<s2>Tooting, London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">01-0190025</idno>
<date when="2001">2001</date>
<idno type="stanalyst">PASCAL 01-0190025 INIST</idno>
<idno type="RBID">Pascal:01-0190025</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000861</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000099</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000840</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000840</idno>
<idno type="wicri:doubleKey">0148-7299:2001:Mansour S:incontinentia:pigmenti:in</idno>
<idno type="wicri:Area/Main/Merge">00A598</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection</title>
<author>
<name sortKey="Mansour, S" sort="Mansour, S" uniqKey="Mansour S" first="S." last="Mansour">S. Mansour</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Department of Medical Genetics, St George's Hospital Medical School</s1>
<s2>Tooting, London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Woffendin, H" sort="Woffendin, H" uniqKey="Woffendin H" first="H." last="Woffendin">H. Woffendin</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Wellcome Trust Centre for Molecular Mechanisms of Disease, Cambridge University Department of Medicine, Cambridge, Addenbrooke's Hospital, Hills Road</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Cambridge</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mitton, S" sort="Mitton, S" uniqKey="Mitton S" first="S." last="Mitton">S. Mitton</name>
<affiliation wicri:level="3">
<inist:fA14 i1="03">
<s1>Department of Child Health, St George's Hospital Medical School</s1>
<s2>Tooting, London</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jeffery, I" sort="Jeffery, I" uniqKey="Jeffery I" first="I." last="Jeffery">I. Jeffery</name>
<affiliation wicri:level="3">
<inist:fA14 i1="04">
<s1>Department of Pathology, St George's Hospital Medical School</s1>
<s2>Tooting, London</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jakins, T" sort="Jakins, T" uniqKey="Jakins T" first="T." last="Jakins">T. Jakins</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Wellcome Trust Centre for Molecular Mechanisms of Disease, Cambridge University Department of Medicine, Cambridge, Addenbrooke's Hospital, Hills Road</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Cambridge</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kenwrick, S" sort="Kenwrick, S" uniqKey="Kenwrick S" first="S." last="Kenwrick">S. Kenwrick</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Wellcome Trust Centre for Molecular Mechanisms of Disease, Cambridge University Department of Medicine, Cambridge, Addenbrooke's Hospital, Hills Road</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Cambridge</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Murday, V A" sort="Murday, V A" uniqKey="Murday V" first="V. A." last="Murday">V. A. Murday</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Department of Medical Genetics, St George's Hospital Medical School</s1>
<s2>Tooting, London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">American journal of medical genetics</title>
<title level="j" type="abbreviated">Am. j. med. genet.</title>
<idno type="ISSN">0148-7299</idno>
<imprint>
<date when="2001">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">American journal of medical genetics</title>
<title level="j" type="abbreviated">Am. j. med. genet.</title>
<idno type="ISSN">0148-7299</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Anhidrotic ectodermal dysplasia</term>
<term>Bullous dermatosis</term>
<term>Case study</term>
<term>Concomitant disease</term>
<term>Family study</term>
<term>Gene</term>
<term>Genetic determinism</term>
<term>Hair</term>
<term>Hemopathy</term>
<term>Human</term>
<term>Immune deficiency</term>
<term>Incontinentia pigmenti</term>
<term>Infection</term>
<term>Lower limb</term>
<term>Lymphedema</term>
<term>Male</term>
<term>Mutation</term>
<term>Osteosclerosis</term>
<term>Pathogenesis</term>
<term>Phenotype</term>
<term>Recurrent</term>
<term>Survival</term>
<term>Transcription factor NFκB</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Incontinentia pigmenti</term>
<term>Etude cas</term>
<term>Homme</term>
<term>Dysplasie ectodermique anhidrotique</term>
<term>Association morbide</term>
<term>Phénotype</term>
<term>Ostéosclérose</term>
<term>Etude familiale</term>
<term>Infection</term>
<term>Lymphoedème</term>
<term>Survie</term>
<term>Mâle</term>
<term>Immunodéficit</term>
<term>Pathogénie</term>
<term>Déterminisme génétique</term>
<term>Hémopathie</term>
<term>Membre inférieur</term>
<term>Récidivant</term>
<term>Mutation</term>
<term>Gène</term>
<term>Dermatose bulleuse</term>
<term>Poil</term>
<term>Facteur transcription NFκB</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Familial Incontinentia pigmenti (IP) is a rare X-linked dominant condition. The affected cases have characteristic skin lesions, hair, eye, teeth and nail abnormalities and may also have neurological problems. The diagnosis has traditionally been made on clinical grounds. Segregation analysis has suggested that it is lethal in males. Only one liveborn male has been reported who died at one day of age. Female cases of IP survive because of the moderating effects of Lyonization. This child was the affected son of a female with IP. He had a novel phenotype consistent with hypohidrotic ectodermal dysplasia with immune deficiency (HED-ID) but with additional features: he had major problems with hematological disturbances, failure to thrive due to malabsorption, recurrent infections, generalized osteosclerosis and lymphedema of his lower limbs. He also demonstrated some typical features of IP with a generalized reticular skin hyperpigmentation, sparse hair and delayed eruption of teeth. The gene for NEMO (NF-κB Essential Modulator) has recently been shown to be mutated in cases of IP. Furthermore, most (80%) of patients possess a recurrent genomic rearrangement that deletes part of the gene resulting in an inactive NEMO protein. In the male case described here, a NEMO stop codon mutation has been identified that has arisen de novo in his affected mother. This mutation is likely to have a less severe effect on NEMO activity and may explain why this child survived for two years and 7 months.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement>
<li>Londres</li>
</settlement>
</list>
<tree>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Mansour, S" sort="Mansour, S" uniqKey="Mansour S" first="S." last="Mansour">S. Mansour</name>
</region>
<name sortKey="Jakins, T" sort="Jakins, T" uniqKey="Jakins T" first="T." last="Jakins">T. Jakins</name>
<name sortKey="Jeffery, I" sort="Jeffery, I" uniqKey="Jeffery I" first="I." last="Jeffery">I. Jeffery</name>
<name sortKey="Kenwrick, S" sort="Kenwrick, S" uniqKey="Kenwrick S" first="S." last="Kenwrick">S. Kenwrick</name>
<name sortKey="Mitton, S" sort="Mitton, S" uniqKey="Mitton S" first="S." last="Mitton">S. Mitton</name>
<name sortKey="Murday, V A" sort="Murday, V A" uniqKey="Murday V" first="V. A." last="Murday">V. A. Murday</name>
<name sortKey="Woffendin, H" sort="Woffendin, H" uniqKey="Woffendin H" first="H." last="Woffendin">H. Woffendin</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00A598 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 00A598 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     Pascal:01-0190025
   |texte=   Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024